Frontline: Control of Anaplasma phagocytophilum, an obligate intracellular pathogen, in the absence of inducible nitric oxide synthase, phagocyte NADPH oxidase, tumor necrosis factor, Toll-like receptor (TLR)2 and TLR4, or the TLR adaptor molecule MyD88

European Journal of Immunology

Volumn 34, Issue 7, 2004, Pages 1789-1797

  von Loewenich, Friederike D ^a,b   Scorpio, Diana G ^c   Reischl, Udo ^d   Dumler, J Stephen ^c   Bogdan, Christian ^a,b  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Anaplasma phagocytophilum; Inducible nitric oxide synthase; MyD88; Phagocyte NADPH oxidase; Tumor necrosis factor

Indexed keywords

ADAPTOR PROTEIN; GLYCOPROTEIN GP 91; INDUCIBLE NITRIC OXIDE SYNTHASE; MYELOID DIFFERENTIATION FACTOR 88; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR; CELL SURFACE RECEPTOR; DIFFERENTIATION ANTIGEN; IMMUNOGLOBULIN RECEPTOR; MEMBRANE PROTEIN; MYD88 PROTEIN, MOUSE; NITRIC OXIDE SYNTHASE; NOS2 PROTEIN, MOUSE; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ANAPLASMA PHAGOCYTOPHILUM; ANAPLASMOSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; BACTERIAL GROWTH; BACTERIAL IMMUNITY; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; DEATH; IN VIVO STUDY; INFECTION CONTROL; INFECTION RESISTANCE; MOUSE; NEUTROPHIL; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; PROTEIN DEFICIENCY; RICKETTSIA; SCID MOUSE; T LYMPHOCYTE; WILD TYPE; ANIMAL; C57BL MOUSE; EHRLICHIOSIS; ENZYMOLOGY; GENETICS; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; MOUSE MUTANT; PHYSIOLOGY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANAPLASMA PHAGOCYTOPHILUM; ANIMALS; ANTIGENS, DIFFERENTIATION; EHRLICHIOSIS; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, SCID; MYELOID DIFFERENTIATION FACTOR 88; NADPH OXIDASE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; RECEPTORS, CELL SURFACE; RECEPTORS, IMMUNOLOGIC; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 3442897088     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200425029     Document Type: Article

References (44)

1. Dumler, J. S., Barbet, A. F., Bekker, C. P. J., Dasch, G. A., Palmer, G. H., Ray, S. C., Rikihisa, Y. and Rurangirwa, F. R., Reorganization of genera in the families Rickettsiaceae and Anaplasmataceae in the order Rickettsiales: unification of some species of Ehrlichia with Anaplasma, Cowdria with Ehrlichia and Ehrlichia with Neorickettsia, descriptions of six new species combinations and designation of Ehrlichia equi and 'HGE agent' as subjective synonyms of Ehrlichia phagocytophila. Int. J. Syst. Evol. Microbiol. 2001. 51: 2145-2165.
2. Bakken, J. S. and Dumler, J. S., Human granulocytic ehrlichiosis. Clin. Infect. Dis. 2000. 31: 554-560.
3. Borjesson, D. L. and Barthold, S. W., The mouse as a model for investigation of human granulocytic ehrlichiosis: current knowledge and future directions. Comp. Med. 2002. 52: 403-413.
4. Martin, M. E., Bunnell, J. E. and Dumler, J. S., Pathology, immunohistology, and cytokine responses in early phases of human granulocytic ehrlichiosis in a murine model. J. Infect. Dis. 2000. 181: 374-378.
5. Hodzic, E., Feng, S., Fish, D., Leutenegger, C. M., Freet, K. J. and Barthold, S. W., Infection of mice with the agent of human granulocytic ehrlichiosis after different routes of inoculation. J. Infect. Dis. 2001. 183: 1781-1786.
6. Sun, W., IJdo, J. W. I., Telford, S. R. I., Hodzic, E., Zhang, Y., Barthold, S. W. and Fikrig, E., Immunization against the agent of human granulocytic ehrlichosis in a murine model. J. Clin. Invest, 1997. 100: 3014-3018.
7. Martin, M. E., Caspersen, K. and Dumler, J. S., Immunopathology and ehrlichial propagation are regulated by interferon-γ and interleukin-10 in a murine model of human granulocytic ehrlichiosis. Am. J. Pathol. 2001. 158: 1881-1888.
8. Akkoyunlu, M. and Fikrig, E., Gamma interferon dominates the murine cytolkine response to the agent of human granulocytic ehrlichiosis and helps to control the degree of early rickettsemia. Infect. Immun. 2000. 68: 1827-1833.
9. Akkoyunlu, M., Malawista, S. E., Anguita, J. and Fikrig, E., Exploitation of interleukin-8-induced neutrophil chemotaxis by the agent of human granulocytic ehrlichiosis. Infect. Immun. 2001. 69: 5577-5588.
10. Bunnell, J. E., Trigiani, E. R., Srinivas, S. R. and Dumler, J. S., Development and distribution of pathologic lesions are related to immune status and tissue deposition of human granulocytic ehrlichiosis agent-infected cells in a murine model system. J. Infect. Dis. 1999. 180: 546-550.
11. Telford, S. R. I., Dawson, J. E., Katavolos, R, Warner, C. K., Kolbert, C. P. and Persing, D. H., Perpetuation of the agent of human granulocytic ehrlichiosis in a deer tick-rodent cycle. Proc. Natl. Acad. Sci. USA 1996. 93: 6209-6214.
12. Hodzic, E., IJdo, J. W. I., Feng, S., Katavolos, P., Sun, W., Maretzki, C. H., Fish, D., Fikrig, E., Telford, S. R. I. and Barthold, S. W., Granulocytic ehrlichiosis in the laboratory mouse. J. Infect. Dis. 1998. 177: 737-745.
13. Borjesson, D. L., Simon, S. I., Tablin, F. and Barthold, S. W., Thrombocytopenia in a mouse model of human granulocytic ehrlichiosis. J. Infect. Dis. 2001. 184: 1475-1479.
14. Lepidi, H., Bunnell, J. E., Martin, M. E., Madigan, J. E., Stuen, S. and Dumler, J. S., Comparative pathology and immunhistology associated with clinical illness after Ehrlichia phagocytophila-group infections. Am. J. Trop. Med. Hyg. 2000. 62: 29-37.
15. Banerjee, R., Anguita, J. and Fikrig, E., Granulocytic ehrlichiosis in mice deficient in phagocyte oxidase or inducible nitric oxide synthase. Infect. Immun. 2000. 68: 4361-4362.
16. Bogdan, C., Röllinghoff, M. and Diefenbach, A., Reactive oxygen and reactive nitrogen intermediates in innate and specific immunity. Curr. Opin. Immunol. 2000. 12: 64-76.
17. -/- mice: protection despite absence of ROI and susceptibility despite presence of RNI. Immunity 1997. 7: 419-432.
18. Wilhelm, P., Ritter, U., Labbow, S., Donhauser, N., Röllinghoff, M, Bogdan, C. and Körner, H., Rapidly fatal leishmaniasis in resistant C57BL/6 mice lacking TNF. J. Immunol. 2001. 166: 4012-4019.
19. Takeda, K., Kaisho, T. and Akira, S., Toll-like receptors. Annu. Rev. Immunol. 2003. 21: 335-376.
20. Bogdan, C., Reactive oxygen and reactive nitrogen metabolites as effector molecules against infectious pathogens. In Kaufmann, S. H. E., Medzhitov, R. and Gordon, S. (Eds.) The innate immune response to infection. ASM Press, Washington 2004 (in press).
21. Park, J. and Rikihisa, Y., L-Arginine-dependent killing of intracellular Ehrlichia risticii by macrophages treated with gamma interferon. Infect. Immun. 1992. 60: 3504-3508.
22. Mott, J. and Rikihisa, Y., Human granulocytic ehrlichiosis agent inhibits superoxide anion generation by human neutrophils. Infect. Immun. 2000. 68: 6697-6703.
23. phox. J. Immunol. 2000. 164: 3946-3949.
24. Wang, T., Malawista, S. E., Pal, U., Grey, M., Meek, J., Akkoyunlu, M., Thomas, V. and Fikrig, E., Superoxide anion production during Anaplasma phagocytophila infection. J. Infect. Dis. 2002. 186: 274-280.
25. Carlyon, J. A., Chan, W.-T., Galan, J., Ross, D. and Fikrig, E., Repression of rac2 mRNA expression by Anaplasma phagocytophila is essential to the inhibition of superoxide production and bacterial proliferation. J. Immunol. 2002. 169: 7009-7018.
26. Mott, J., Rikihisa, Y. and Tsunawaki, S., Effects of Anaplasma phagocytophila on NADPH oxidase components in human neutrophils and HL-60 cells. Infect. Immun. 2002. 70: 1359-1366.
27. Barton, G. M. and Medzhitov, R., Toll-like receptors and their ligands. Curr. Top. Microbiol. Immunol. 2002. 270: 81-92.
28. Choi, K. S., Scorpio, D. G. and Dumler, J. S., Anaplasma phagocytophilum ligation to TLR2 but not to TLR4 activates macrophages for NF-κB nuclear translocation. J. Infect. Dis. 2004, in press.
29. Feng, C. G., Scanga, C. A., Collazo-Custodio, C. M., Cheever, A. W., Hieny, S., Caspar, P. and Sher, A., Mice lacking myeloid differentiation factor 88 display profound defects in host resistance and immune responses to Mycobacterium avium infection not exhibited by Toll-like receptor 2 (TLR2)- and TLR4-deficient animals. J. Immunol. 2003. 171: 4758-4764.
30. Sugawara, I., Yamada, H., Mizuno, S., Takeda, K. and Akira, S., Mycobacterial infection in MyD88-deficient mice. Microbiol. Immunol. 2003. 47: 841-847.
31. Edelson, B. T. and Unanue, E. R., MyD88-dependent but Toll-like receptor 2-independent innate immunity to Listeria: no role for either in macrophage listericidal activity. J. Immunol. 2002. 169: 3869-3875.
32. Scanga, C. A., Aliberti, J., Jankovic, D., Tilloy, F., Bennouna, S., Denkers, E. Y., Medzhitov, R. and Sher, A., MyD88 is required for resitance to Toxoplasma gondii infection and regulates parasite-induced IL-12 production by dendritic cells. J. Immunol. 2002. 168: 5997-6001.
33. Muraille, E., De Trez, C., Brait, M., De Baetselier, R, Leo, O. and Carlier, Y., Genetically resistant mice lacking MyD88-adapter protein display a high susceptibility to Leishmania major infection associated with a polarized Th2 response. J. Immunol. 2003. 170: 4237-4241.
34. de Veer, M. J., Curtis, J. M., Baldwin, T. M., DiDonato, J. A., Sexton, A., McConville, M. J., Handman, E. and Schofield, L., MyD88 is essential for clearance of Leishmania major: possible role of lipophosphoglycan and Toll-like receptor 2 signaling. Eur. J. Immunol. 2003. 33: 2822-2831.
35. Debus, A., Gläsner, J., Röllinghoff, M. and Gessner, A., High levels of susceptibility and T helper 2 response in MyD88-deficient mice infected with Leishmania major are interleukin-4 dependent. Infect Immun. 2003. 71: 7215-7218.
36. Reiling, N., Hölscher, C., Fehrenbach, A., Kröger, S., Kirschning, C. J., Goyert, S. and Ehlers, S., Toll-like receptor (TLR)2-and TLR4-mediated pathogen recognition in resistance to airborne infection with Mycobacterium tuberculosis. J. Immunol. 2002. 169: 3480-3484.
37. Rikihisa, Y., Perry, B. D. and Cordes, D. O., Ultrastructural study of ehrlichial organisms in the large colon of ponies with Potomac horse fever. Infect. Immun. 1985. 49: 505-512.
38. Lin, M. and Rikihisa, Y., Ehrlichia chaffeensis and Anaplasma phagocytophilum lack genes for lipid A biosynthesis and incorporate cholesterol for their survival. Infect. Immun. 2003. 71: 5324-5331.
39. Akira, S. and Sato, S., Toll-like receptors and their signaling mechanisms. Scand. J. Infect. Dis. 2003. 35: 555-562.
40. Körner, H., Cook, M., Riminton, D. S., Lemckert, F. A., Hoek, R., Ledermann, B., Köntgen, F., Fazekas de St. Groth, B. and Sedgwick, J. D., Distinct roles for lymphotoxin-α and tumor necrosis factor in lymphoid tissue organogenesis and spatial organization defined in gene-targeted C57BL/6 mice. Eur. J. Immunol. 1997. 27: 2600-2609.
41. Adachi, O., Kawai, T., Takeda, K., Matsumoto, M., Tsutsui, H., Sakagami, M., Nakanishi, K. and Akira, S., Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 1998. 9: 143-150.
42. Takeuchi, O., Hoshino, K., Kawai, T., Sanjo, H., Takada, H., Ogawa, T., Takeda, K. and Akira, S., Differential roles of TLR2 and TLR4 in recognition of Gram-negative and Gram-positive bacterial cell wall components. Immunity 1999. 11: 443-451.
43. Gribble, D. H., Equine ehrlichiosis. J. Am. Vet. Med. Assoc. 1969. 155: 462-469.
44. Walls, J. J., Caturegli, R, Bakken, J. S., Asanovich, K. M. and Dumler, J. S., Improved sensitivity of PCR for diagnosis of human granulocytic ehrlichiosis using epank1 genes of Ehrlichia phagocytophila-group Ehrlichiae. J. Clin. Microbiol. 2000. 38: 354-356.